KBC Group’s Avidity Biosciences RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$96K Sell
3,375
-1,099
-25% -$31.3K ﹤0.01% 1227
2025
Q1
$132K Hold
4,474
﹤0.01% 1323
2024
Q4
$130K Buy
4,474
+2,226
+99% +$64.7K ﹤0.01% 1375
2024
Q3
$103K Hold
2,248
﹤0.01% 1267
2024
Q2
$92K Buy
+2,248
New +$92K ﹤0.01% 1223